Antigenic and genetic characterization of serotype G2 human rotavirus strains from the African continent

被引:35
作者
Page, NA [1 ]
Steele, AD [1 ]
机构
[1] Med Univ S Africa, MRC Medunsa Diarrhoeal Pathogens Res Unit, ZA-0204 Medunsa, South Africa
关键词
D O I
10.1128/JCM.42.2.595-600.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Serotype G2 rotavirus strains were isolated in seven countries on the African continent during 1999 and 2000. To investigate the associated DS-1 genogroup characteristics, subgroup (VP6) enzyme-linked immunosorbent assay, polyacrylamide gel electrophoresis, and P genotyping were performed on 10 G2 strains. The antigenic and genetic variation of the gene encoding the major neutralization glycoprotein (VP7) was also investigated by using G2-specific monoclonal antibodies and sequence analysis. Alterations in the characteristic DS-1 genogroup gene constellations were more likely to occur in the VP4 gene, and three genotypes were observed: P[4], P[6], and a dual P[4]-P[6] type. The failure of G2-specific monoclonal antibodies to type African G2 strains was more likely due to improper storage of the original stool, although G2 monotypes were detected. Phylogenetic analyses revealed clusters of serotype G2 strains that were more commonly associated with seasons during which G2 was predominant. No rotavirus vaccine trials have been conducted in an area where G2 strains were the predominant circulating serotype, and the continued surveillance of rotavirus epidemics in Africa will be preparation for future vaccine implementation in an area that clearly needs these preventative medicines.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 47 条
[1]   Molecular epidemiology of rotaviruses in Nigeria: Detection of unusual strains with G2P[6] and G8P[1] specificities [J].
Adah, MI ;
Wade, A ;
Taniguchi, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) :3969-3975
[2]   REASSORTMENT OF HUMAN ROTAVIRUSES CARRYING REARRANGED GENOMES WITH BOVINE ROTAVIRUS [J].
ALLEN, AM ;
DESSELBERGER, U .
JOURNAL OF GENERAL VIROLOGY, 1985, 66 :2703-2714
[3]  
Armah GE, 2001, J MED VIROL, V63, P67, DOI 10.1002/1096-9071(200101)63:1&lt
[4]  
67::AID-JMV1010&gt
[5]  
3.0.CO
[6]  
2-T
[7]   ENZYME-LINKED IMMUNOSORBENT ASSAYS BASED ON POLYCLONAL AND MONOCLONAL-ANTIBODIES FOR ROTAVIRUS DETECTION [J].
BEARDS, GM ;
CAMPBELL, AD ;
COTTRELL, NR ;
PEIRIS, JSM ;
REES, N ;
SANDERS, RC ;
SHIRLEY, JA ;
WOOD, HC ;
FLEWETT, TH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (02) :248-254
[8]   Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial [J].
Bernstein, DI ;
Sack, DA ;
Rothstein, E ;
Reisinger, K ;
Smith, VE ;
O'Sullivan, D ;
Spriggs, DR ;
Ward, RL .
LANCET, 1999, 354 (9175) :287-290
[9]   PROTECTION CONFERRED BY NEONATAL ROTAVIRUS INFECTION AGAINST SUBSEQUENT ROTAVIRUS DIARRHEA [J].
BHAN, MK ;
LEW, JF ;
SAZAWAL, S ;
DAS, BK ;
GENTSCH, JR ;
GLASS, RI .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) :282-287
[10]   Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries [J].
Bresee, JS ;
Glass, RI ;
Ivanoff, B ;
Gentsch, JR .
VACCINE, 1999, 17 (18) :2207-2222